Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Key drivers of family-level utility of pediatric genomic sequencing: a qualitative analysis to support preference research

Abstract

Given that pediatric genomic sequencing (GS) may have implications for the health and well-being of both the child and family, a clearer understanding of the key drivers of the utility of GS from the family perspective is needed. The purpose of this study is to explore what is important to caregivers of pediatric patients regarding clinical GS, with a focus on family-level considerations. We conducted semi-structured interviews with caregivers (n = 41) of pediatric patients who had been recommended for or completed GS that explored the scope of factors caregivers considered when deciding whether to pursue GS for their child. We analyzed the qualitative data in multiple rounds of coding using thematic analysis. Caregivers raised important family-level considerations, in addition to those specifically for their child, which included wanting the best chance at good quality of life for the family, the ability to learn about family health, the impact on the caregiver’s well-being, privacy concerns among family members, and the cost of testing to the family. We developed a framework of key drivers of utility consisting of four domains that influenced caregivers’ decision making: underlying values, perceived benefits, perceived risks, and other pragmatic considerations regarding GS. These findings can inform measurement approaches that better capture the utility of pediatric GS for families and improve assessments of the value of clinical GS.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1: Framework of key drivers of family-lelve utility of genomic sequencing.

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  1. Regier DA, Weymann D, Buchanan J, Marshall DA, Wordsworth S. Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and Solutions. Value Health. 2018;21:1043–7.

    Article  PubMed  Google Scholar 

  2. Smith HS, McGuire AL, Wittenberg E, Lavelle TA. Family-level impact of genetic testing: integrating health economics and ethical, legal, and social implications. Personalized Med. 2021;18:209–12.

    Article  Google Scholar 

  3. Kohler JN, Turbitt E, Biesecker BB. Personal utility in genomic testing: a systematic literature review. Eur J Hum Genet. 2017;25:662–8.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Mollison L, O’Daniel JM, Henderson GE, Berg JS, Skinner D. Parents’ perceptions of personal utility of exome sequencing results. Genet Med. 2020;22:752–7.

    Article  PubMed  Google Scholar 

  5. Kohler JN, Turbitt E, Lewis KL, Wilfond BS, Jamal L, Peay HL, et al. Defining personal utility in genomics: A Delphi study. Clin Genet. 2017;92:290–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Watnick D, Odgis JA, Suckiel SA, Gallagher KM, Teitelman N, Donohue KE, et al. "Is that something that should concern me?": a qualitative exploration of parent understanding of their child’s genomic test results. HGG Adv. 2021;2:100027.

  7. Pollard S, Weymann D, Dunne J, Mayanloo F, Buckell J, Buchanan J, et al. Toward the diagnosis of rare childhood genetic diseases: what do parents value most? Eur J Hum Genet. 2021;29(10):1491–501.

  8. Lee W, Luca S, Costain G, Snell M, Marano M, Curtis M, et al. Genome sequencing among children with medical complexity: What constitutes value from parents’ perspective? J.J Genet Couns. 2022;31:523-33.

  9. Neumann PJ, Goldie SJ, Weinstein MC. Preference-based measures in economic evaluation in health care. Annu Rev Public Health. 2000;21:587–611.

    Article  CAS  PubMed  Google Scholar 

  10. Soekhai V, de Bekker-Grob EW, Ellis AR, Vass CM. Discrete choice experiments in health economics: past, present and future. PharmacoEconomics 2019;37:201–26.

    Article  PubMed  Google Scholar 

  11. Ryan M, Gerard K, Amaya-Amaya M. Using discrete choice experiments to value health and health care: Springer Science & Business Media; 2007.

  12. Mühlbacher A, Johnson FR. Choice experiments to quantify preferences for health and healthcare: state of the practice. Appl health Econ health policy. 2016;14:253–66.

    Article  PubMed  Google Scholar 

  13. Ozdemir S, Lee JJ, Chaudhry I, Ocampo RRQ. A Systematic Review of Discrete Choice Experiments and Conjoint Analysis on Genetic Testing. Patient - Patient-Centered Outcomes Res. 2022;15:39–54.

    Article  Google Scholar 

  14. Coast J, Horrocks S. Developing attributes and levels for discrete choice experiments using qualitative methods. J health Serv Res Policy. 2007;12:25–30.

    Article  PubMed  Google Scholar 

  15. Coast J, Al‐Janabi H, Sutton EJ, Horrocks SA, Vosper AJ, Swancutt DR, et al. Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations. Health Econ. 2012;21:730–41.

    Article  PubMed  Google Scholar 

  16. Kløjgaard ME, Bech M, Søgaard R. Designing a stated choice experiment: the value of a qualitative process. J Choice Model. 2012;5:1–18.

    Article  Google Scholar 

  17. Best S, Stark Z, Phillips P, Wu Y, Long JC, Taylor N, et al. Clinical genomic testing: what matters to key stakeholders? Eur J Hum Genet. 2020;28:866–73.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Abbott M, McKenzie L, Moran BVG, Heidenreich S, Hernández R, Hocking-Mennie L, et al. Continuing the sequence? Towards an economic evaluation of whole genome sequencing for the diagnosis of rare diseases in Scotland. J Commun Genet. 2022;13:487–501.

  19. Hammond J, Klapwijk JE, Riedijk S, Lou S, Ormond KE, Vogel I, et al. Assessing women’s preferences towards tests that may reveal uncertain results from prenatal genomic testing: Development of attributes for a discrete choice experiment, using a mixed-methods design. PLoS One. 2022;17:e0261898.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Vass C, Rigby D, Payne K. The Role of Qualitative Research Methods in Discrete Choice Experiments. Med Decis Mak. 2017;37:298–313.

    Article  Google Scholar 

  21. Smith HS, Morain SR, Robinson JO, Canfield I, Malek J, Rubanovich CK, et al. Perceived Utility of Genomic Sequencing: Qualitative Analysis and Synthesis of a Conceptual Model to Inform Patient-Centered Instrument Development. The Patient - Patient-Centered Outcomes Research. 2021.

  22. Halley MC, Young JL, Fernandez L, Kohler JN, Bernstein JA, Wheeler MT, et al. Perceived utility and disutility of genomic sequencing for pediatric patients: Perspectives from parents with diverse sociodemographic characteristics. Am J Med Genet A 2022;188:1088–101.

    Article  PubMed  Google Scholar 

  23. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42:377–81.

    Article  Google Scholar 

  24. Chassagne A, Pélissier A, Houdayer F, Cretin E, Gautier E, Salvi D, et al. Exome sequencing in clinical settings: preferences and experiences of parents of children with rare diseases (SEQUAPRE study). Eur J Hum Genet. 2019;27:701–10.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Lewis MA, Stine A, Paquin RS, Mansfield C, Wood D, Rini C, et al. Parental preferences toward genomic sequencing for non-medically actionable conditions in children: a discrete-choice experiment. Genet Med. 2018;20:181–9.

    Article  PubMed  Google Scholar 

  26. Marshall DA, MacDonald KV, Heidenreich S, Hartley T, Bernier FP, Gillespie MK, et al. The value of diagnostic testing for parents of children with rare genetic diseases. Genet Med. 2019;21:2798–806.

    Article  PubMed  Google Scholar 

  27. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care. 1988;26:724–35.

    Article  CAS  PubMed  Google Scholar 

  28. Braun V, Clarke V. Thematic analysis. APA handbook of research methods in psychology, Vol 2: Research designs: Quantitative, qualitative, neuropsychological, and biological. APA handbooks in psychology®. Washington, DC, US:, American Psychological Association; 2012. p. 57-71.

  29. VERBI Software MAXQDA 2022 Berlin, Germany: VERBI Software; 2021.

  30. Hollin IL, Craig BM, Coast J, Beusterien K, Vass C, DiSantostefano R, et al. Reporting Formative Qualitative Research to Support the Development of Quantitative Preference Study Protocols and Corresponding Survey Instruments: Guidelines for Authors and Reviewers. The Patient - Patient-Centered Outcomes. Research. 2020;13:121–36.

    Google Scholar 

  31. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349–57.

    Article  PubMed  Google Scholar 

  32. Texas Children’s Hospital Genetics Clinic 2020 [Available from: https://www.texaschildrens.org/departments/genetics.

Download references

Funding

Dr. Smith is supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number K99HG011491. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author information

Authors and Affiliations

Authors

Contributions

HSS confirms that she had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors gave final approval of this version to be published and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Corresponding author

Correspondence to Hadley Stevens Smith.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

Approval to conduct this human subjects research was obtained by the Baylor College of Medicine Institutional Review Board. Verbal informed consent was obtained from all participants for being included in the study.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Smith, H.S., Bonkowski, E.S., Deloge, R.B. et al. Key drivers of family-level utility of pediatric genomic sequencing: a qualitative analysis to support preference research. Eur J Hum Genet (2022). https://doi.org/10.1038/s41431-022-01245-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41431-022-01245-0

Search

Quick links